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Abstract: 
Xuan-Ju agent is an herbal formula containing aqueous extract of Formica fusca, Herba 
epimedii, Fructus cnidii, and Fructus lycii, all of which are reputed for their beneficial effects in 
the treatment of the immunodeficient diseases such as rheumatoid arthritis. We performed a 
study on the anti-inflammatory effects of this agent using carrageenan- and adjuvant-induced 
paw edema in rats. Xuan-Ju agent showed a marked inhibitory effect on edema in two models of 
inflammation in rats, at the dose of 0.20, 0.40 and 0.80 g/kg. Based on this study, Xuan-Ju agent 
is considered to be a potentially useful drug suitable for further evaluation for rheumatoid 
arthritis. 
 
Article: 
INTRODUCTION 
Anti-inflammatory drugs, presently available for the treatment of joint inflammation of various 
kinds, have undesirable side effects such as causing peptic ulcers (Pascucci, 2002, Corley et al., 
2003 and Flower et al., 1980). Therefore, plant remedies have become increasingly popular and 
are often preferred to synthetically derived pharmaceuticals. 
 
An attempt was made in our laboratory to search for herbal-based anti-inflammatory products 
known to have beneficial effects for rheumatic disorders in traditional medicines. A new drug 
formula, Xuan-Ju agent, was prepared using aqueous extract of Formica fusca, Herba epimedii, 
Fructus cnidii, and Fructus lycii. In this combination formula, Formica fusca is dried ant, which 
has been used in Chinese folk medicine for the treatment of rheumatoid arthritis (Tang, 2003). 
Other three herbal medicines have been listed in Chinese Pharmacopoeia 2000 edition. Herba 
epimedii is dried branch and leaf of Epimedium sagittatum (Sieb. Et Zucc.) Maxim., family 
Berberidaceae, and traditionally used for impotence due to deficiency of the kidney; Fructus lycii 
is the mature fruit of Cycium barbarum L., family Solanaceae, and traditionally used for 
deficiency of liver-yin and kidney-yin and diabetes; Fructus cnidii is the dried ripe fruit of 
Cnidium onnierii (L.) cusson, family Umbelliferae, and traditionally used for deficiency of 
kidney-yang, and pudendum itching caused by dampness and eczema (Tang, 2003). We 
performed a pharmacological investigation on the anti-inflammatory activity of this agent using 
carrageenin- and adjuvant-induced animal models. 
 
MATERIALS AND METHODS 
Animals 
Male Wistar rats, 4–6 weeks old were obtained from the Experiment Center of Beijing Medical 
University, China. They were housed in air-conditioned room at 25 °C, and fed with a standard 
laboratory feed and tap water throughout the experiments. Rats weighing 130–160 g were used 
in the study. 
 
Materials 
Xuan-Ju agent was prepared by mixing 220 g of dry ant (10%), 666 g of Herba epimedii (30%), 
666 g of Fructus cnidii (30%), and 666 g of Fructus lycii (30%) and decocting the mixture with 
1:1 (v/v) boiling water three times for 1 h. The decoction was filtered, mixed, concentrated, and 
dried into powder. Each gram of Xuan-Ju agent is equivalent to 5 g of dried starting materials 
(mixed with the same ratio as described above). The powder of Xuan-Ju agent was mixed with 
distilled water upon oral administration. 
 
Carrageenin-induced paw edema in rats 
This anti-inflammatory test was performed according to the method of Winter et al. (1962). 
Edema in the left hind paw of rat was induced by injection of 0.1 ml of 1% (w/v) carrageenan 
(Sigma, St. Louis, MO) in saline into the footpad, subcutaneously. The perimeter of the paw was 
measured before injection and then at 1, 2, 4, 6 h, and the edema value was expressed with the 
difference between the perimeter of paw at certain time point after injection and the one before 
injection. The Xuan-Ju agent at three dose levels (0.8, 0.4, and 0.2 g/kg, p.o.) and distilled water 
were given 30 min to the treatment groups and control group, respectively, before carrageenan 
injection. Another group of rats was orally administered with acetylsalicylic acid (10 mg/kg) as a 
standard reference. The edema inhibition rate was calculated as follows: 
 
 
where Vc is the edema value of the control group; and Vt is the edema value of treated group. 
 
Adjuvant-induced arthritis in rats 
Experimental arthritis was induced in rats according to the method of Newbould (1963). The 
right footpad of each rat was injected subcutaneously with 0.1 ml of complete-Freund’s adjuvant 
agent (CFA, Sigma). The Xuan-Ju agent at three dose levels (0.8, 0.4, and 0.2 g/kg, p.o.), 
distilled water, and acetylsalicylic acid at 10 mg/kg were given daily to the treatment groups, 
control group, and reference group, respectively, starting at 8 days after CFA injection for 14 
consecutive days. The edema of the left and right hind paws was evaluated at 2 h, 8, 12, 16, and 
24 days post-injection of CFA. The inhibition rate was calculated with the same method as 
described above. 
 
 
 
 
Statistical analysis 
Data were expressed as mean, standard deviation (S.D.) and statistically assessed by one-way 
analysis of variance (ANOVA). Difference between drug-treated groups and control group was 
evaluated by Dunnett’s t-test. P<0.05 was considered significant. 
 
RESULTS 
Effect on carrageenan-induced rat paw edema 
The rat’s footpad became edemateous soon after injection of carrageenan. Edema value of the 
injected footpad reached its peak at 4 h (the perimeter of paw increased by 0.67 cm). 
Administration of Xuan-Ju agent at 0.2, 0.4, and 0.8 g/kg significantly inhibited the development 
of pad swelling from 1 to 6 h after carrageenan injection (P<0.01, Table 1). The results showed 
that Xuan-Ju agent at a dose of 0.8 g/kg has the most potent anti-inflammatory effects. The 
reference drug, acetylsalicylic acid at 10 mg/kg, had significant anti-inflammatory effect, similar 
to the treatment group with the highest dose, 0.8 g/kg. 
 
Table 1: Effects of Xuan-Ju agent on carrageenan-induced paw edema in rats (n=10) 
Group Dose (g/kg) Edema value (cm, )  Inhibition rate (%) 
  1 h 2 h  4 h 6 h 
Control – 0.49 ± 0.11 0.64 ± 0.14  0.67 ± 0.12 0.63 ± 0.12 
 
Xuan-Ju agent 
 
0.8 
 
0.35 ± 0.15* (28.6) 
 
0.40 ± 0.16** (37.5) 
 
 
 
0.40 ± 0.16** (40.3) 
 
0.38 ± 0.15** (39.7) 
 0.4 0.37 ± 0.13* (24.5) 0.46 ± 0.13* (28.1)  0.50 ± 0.11** (25.4) 0.49 ± 0.13* (22.2) 
 0.2 0.38 ± 0.16* (22.4) 0.48 ± 0.19* (25.0)  0.51 ± 0.16* (23.9) 0.48 ± 0.14* (23.8) 
 
Acetylsalicylic acid 
 
0.01 
 
0.36 ± 0.13* (26.5) 
 
0.42 ± 0.14** (34.4) 
 
 
 
0.45 ± 0.15** (32.8) 
 
0.42 ± 0.19** (33.3) 
Values represent the mean±S.D. of 10 animals for each group. Values in parentheses indicate the percentage inhibition rate. 
*Statistically significant from control: P<0.05. 
**Statistically significant from control: P<0.01. 
 
Effect on adjuvant-induced rat paw edema 
Table 2 showed the time course of edema and inhibition rate after the administration of CFA and 
Xuan-Ju agent. The left hind paw also developed edema in addition to the right footpad. Edema 
value of the injected footpad and the left hind paw increased and reached a peak at 12 days. 
Administration of Xuan-Ju agent at a dose of 0.2 g/kg significantly inhibited the development of 
the swelling induced by CFA. Three different doses of Xuan-Ju agent all exhibited anti-
inflammatory activity which was maintained until the experiment was terminated on day 24. 
 
Table 2: Effects of Xuan-Ju agent on CFA-induced paw edema in rats, (n=10) 
Days Group 
 Control Reference  Xuan-Ju agent 
  0.1 g/kg 0.8 g/kg  0.4 g/kg 0.2 g/kg 
8a 0.85 ± 0.11 0.74 ± 0.13 (12.9) 0.74 ± 0.14 (12.9)  0.78 ± 0.09 (8.2) 0.76 ± 0.14 (10.6) 
12 0.93 ± 0.11 0.75 ± 0.15* (19.4) 0.72 ± 0.12** (22.6)  0.76 ± 0.10** (18.3) 0.77 ± 0.19 (17.2) 
16 0.90 ± 0.11 0.70 ± 0.19* (22.2) 0.68 ± 0.12** (24.4)  0.69 ± 0.14** (23.3) 0.70 ± 0.18* (22.2) 
20 0.87 ± 0.11 0.66 ± 0.20* (18.9) 0.65 ± 0.16** (25.3)  0.66 ± 0.15** (24.1) 0.69 ± 0.16* (20.7) 
24 0.80 ± 0.12 0.62 ± 0.17* (22.5) 0.59 ± 0.17** (26.3)  0.60 ± 0.12** (25.0) 0.66 ± 0.19 (17.5) 
Left foot       
 8a 0.39 ± 0.09 0.34 ± 0.12 (12.8) 0.31 ± 0.11* (20.5)  0.34 ± 0.08 (12.8) 0.32 ± 0.09 (17.9) 
 12 0.51 ± 0.09 0.38 ± 0.14* (25.5) 0.37 ± 0.12** (27.5)  0.39 ± 0.07* (23.5) 0.41 ± 0.11* (19.6) 
 16 0.48 ± 0.09 0.35 ± 0.12* (27.1) 0.36 ± 0.13* (25.0)  0.37 ± 0.09 (22.9) 0.38 ± 0.11 (20.8) 
 20 0.46 ± 0.07 0.34 ± 0.11** (26.1) 0.32 ± 0.10** (30.4)  0.32 ± 0.09** (30.4) 0.38 ± 0.11 (17.4) 
 24 0.40 ± 0.08 0.31 ± 0.11 (22.5) 0.29 ± 0.12 (27.5)  0.30 ± 0.08* (21.5) 0.34 ± 0.13 (15.0) 
Values in parentheses indicate the percentage inhibition rate. 
aEdema value was measured at 2h after the drug administration, which was performed at 8 days after the CFA injection. 
*Statistically significant from control, P<0.05. **Statistically significant from control, P<0.01. 
DISCUSSION 
Our results showed that in tests of short duration, such as carrageenan-induced edema in rats, as 
well as in tests of longer duration, such as CFA-induced arthritis in rats, Xuan-Ju agent at 0.2, 
0.4, and 0.8 g/kg exhibited significant anti-inflammatory effects. Based on these preliminary 
observations, Xuan-Ju agent is considered a drug candidate to be chosen for further evaluation 
including clinical investigations for rheumatoid arthritis. Further studies on identification and 
isolation of active components in Xuan-Ju agent as well as mode of action are under 
investigation. 
 
Rheumatoid arthritis is an autoimmune disease characterized by chronic inflammation, 
hyperproliferation of the synovial lining and cartilage destruction (Schiff, 1997). Although many 
plant extracts have been clinically used as anti-inflammatory remedies in the treatment of 
rheumatoid arthritis, their mode of action remains unclear (Wang and Zhang, 2002). The 
interaction between the compounds from medicinal plants and the diseased state of rheumatism 
might be far more complex than merely the result of an anti-inflammatory activity exerted by a 
single phytochemical molecule or a group of isolates. We believe traditional formulas containing 
combination herbal medicines hold the potential to become the therapeutics of choice in future 
due to the synergistic effect achieved by the multiple ingredients that may relieve the 
inflammation and pain, strengthen the impaired immune system, restore the damaged bone and 
cartilage, and improve the overall symptoms associated with the arthritis. 
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